SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-10-006977
Filing Date
2010-08-04
Accepted
2010-08-04 12:16:26
Documents
1
Period of Report
2010-09-15
Effectiveness Date
2010-08-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2199573zdef14a.htm DEF 14A 406220
  Complete submission text file 0001047469-10-006977.txt   407848
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 10990180
SIC: 2835 In Vitro & In Vivo Diagnostic Substances